| 101 |
10208419 | Rho-dependent and -independent tyrosine phosphorylation of focal adhesion kinase, paxillin and p130Cas mediated by Ret kinase. | 1999 Mar 18 |
2 |
| 102 |
10442282 | [A case of multiple endocrine neoplasia type 2A (MEN2A) with a mutation in the RET gene]. | 1999 Jun |
1 |
| 103 |
10448070 | Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signalling molecules mediated by ret with the MEN 2B mutation. | 1999 Aug 19 |
2 |
| 104 |
10465268 | The role of amino acids surrounding tyrosine 1062 in ret in specific binding of the shc phosphotyrosine-binding domain. | 1999 Sep |
1 |
| 105 |
10484767 | Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site. | 1999 Oct |
1 |
| 106 |
9528752 | Protein kinase B activation and lamellipodium formation are independent phosphoinositide 3-kinase-mediated events differentially regulated by endogenous Ras. | 1998 Apr |
1 |
| 107 |
9528800 | Shc and Enigma are both required for mitogenic signaling by Ret/ptc2. | 1998 Apr |
3 |
| 108 |
9582017 | Activation loop tyrosines contribute varying roles to TrkB autophosphorylation and signal transduction. | 1998 Apr 2 |
1 |
| 109 |
9627110 | Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret. | 1998 May 14 |
2 |
| 110 |
9681851 | Molecular mechanisms of development of multiple endocrine neoplasia 2 by RET mutations. | 1998 Jun |
6 |
| 111 |
9764818 | Grb2 binding to the different isoforms of Ret tyrosine kinase. | 1998 Sep 3 |
4 |
| 112 |
9012462 | The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. | 1997 Feb 1 |
1 |
| 113 |
9035202 | The RET proto-oncogene: a challenge to our understanding of disease pathogenesis. | 1997 |
2 |
| 114 |
9047384 | Identification of Shc docking site on Ret tyrosine kinase. | 1997 Feb 20 |
3 |
| 115 |
9192898 | A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. | 1997 Jun 12 |
2 |
| 116 |
9393871 | The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck. | 1997 Nov 6 |
6 |
| 117 |
8621380 | Oncogenic RET receptors display different autophosphorylation sites and substrate binding specificities. | 1996 Mar 8 |
2 |
| 118 |
8628282 | The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma. | 1996 May |
12 |
| 119 |
8637703 | Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation. | 1996 Feb 1 |
15 |
| 120 |
8657281 | Functional receptor for GDNF encoded by the c-ret proto-oncogene. | 1996 Jun 27 |
1 |
| 121 |
8657309 | Characterization of a multicomponent receptor for GDNF. | 1996 Jul 4 |
1 |
| 122 |
8662982 | Mitogenic signaling by Ret/ptc2 requires association with enigma via a LIM domain. | 1996 May 31 |
5 |
| 123 |
8663233 | Specificity of LIM domain interactions with receptor tyrosine kinases. | 1996 Jul 5 |
1 |
| 124 |
8663426 | A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins. | 1996 Jul 26 |
11 |
| 125 |
8670046 | A mutation in the RET proto-oncogene in Hirschsprung's disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B. | 1996 Mar 1 |
4 |
| 126 |
8765374 | [Detection of RET-proto-oncogene mutations in the diagnosis of Type 2 endocrine neoplasia (MEN 2)]. | 1996 Aug 6 |
1 |
| 127 |
8855235 | Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis. | 1996 Oct 1 |
1 |
| 128 |
7532281 | Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. | 1995 Mar |
1 |
| 129 |
8556060 | Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (Sipple's syndrome). | 1995 Aug |
1 |
| 130 |
8570194 | RET activation by germline MEN2A and MEN2B mutations. | 1995 Dec 7 |
4 |
| 131 |
7510705 | Basic fibroblast growth factor-induced low density lipoprotein receptor transcription and surface expression. Signal transduction pathways mediated by the bFGF receptor tyrosine kinase. | 1994 Mar 25 |
1 |
| 132 |
7914213 | Identification of the Cys634-->Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis. | 1994 Mar |
5 |
| 133 |
8183561 | The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins. | 1994 Jun |
3 |
| 134 |
7678053 | Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A. | 1993 Jan |
1 |
| 135 |
7685595 | Tyrosine kinase activity of the ret proto-oncogene products in vitro. | 1993 Jun 15 |
2 |
| 136 |
8363602 | Inhibition of ret tyrosine kinase activity by herbimycin A. | 1993 Aug 31 |
1 |
| 137 |
8487750 | Identification of an autoinhibitory domain in the insulin receptor tyrosine kinase. | 1993 Mar 24 |
2 |
| 138 |
1437145 | Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas. | 1992 Nov |
1 |
| 139 |
1572907 | Regulation of TGF-alpha expression in human keratinocytes: PKC-dependent and -independent pathways. | 1992 May |
1 |